GILEAD SCIENCES, INC. ($1,000,000,000 Aggregate Principal Amount) Underwriting AgreementUnderwriting Agreement • March 28th, 2011 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The Securities will be issued pursuant to an Indenture to be dated as of March 30, 2011 (the “Indenture”) between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”).
